The Latest in Non-Hodgkin Lymphoma

Quick FDA approval for brentuximab vedotin in PTCL

November 16, 2018

R-CHOP effective as first-line treatment in FL

November 16, 2018

Selinexor on fast track for DLBCL

November 8, 2018

Combo appears safe, active in rel/ref NHL

November 6, 2018

Sandoz won’t seek U.S. approval for rituximab biosimilar

November 6, 2018

Health Canada approves pralatrexate for rel/ref PTCL

November 2, 2018

EC approves venetoclax in combo with rituximab

November 2, 2018

Novel risk factors for febrile neutropenia in NHL, other cancers

November 1, 2018

Combo can prolong overall survival in MCL

October 25, 2018

BTK inhibitor shows early promise for WM

October 18, 2018

sNDA gets priority review for CLL/SLL

October 18, 2018

Understanding the role of HSCT in PTCL

October 17, 2018

FDA issues draft guidance on MRD

October 16, 2018

Inhibitor receives orphan designation for PTCL

October 11, 2018

Phase 1 NHL, ALL trials placed on clinical hold

October 10, 2018